| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 67,970 | 62,429 | 68,483 | 85,140 | | Cost of Revenue | 54,783 | 54,521 | 61,376 | 64,060 | | | Gross Profit | 13,187 | 7,908 | 7,107 | 21,080 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,192 | 3,890 | 4,081 | 4,128 | | Non Recurring | 170,991 | 6,853 | 167,453 | 210,162 | | Others | 3,152 | 3,162 | 2,254 | 4,098 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (164,148) | (5,997) | (166,681) | (197,308) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,059) | 33,510 | 1,455 | 751 | | Earnings Before Interest And Taxes | (165,207) | 27,513 | (165,885) | (196,557) | | Interest Expense | 5,336 | 5,619 | 5,198 | 6,732 | | Income Before Tax | (170,543) | 21,894 | (171,083) | (203,289) | | Income Tax Expense | (38,428) | 5,614 | 8,255 | (80,780) | | Minority Interest |
-
|
-
| (1,145) | (846) | | | | Net Income From Continuing Ops | (132,115) | 16,280 | (180,483) | (123,355) | | | Non-recurring Events | | Discontinued Operations | 27 | (588) | (1,053) | (56) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (132,088) | 15,692 | (181,536) | (123,411) | | Preferred Stock And Other Adjustments | (3,473) | (3,705) | (2,195) | (2,246) | | | Net Income Applicable To Common Shares | ($135,561) | $11,987 | ($183,731) | ($125,657) |
|
1.29% Nasdaq 
0.06 (5.41%) 
Income Statement
